I agree that this site is using cookies. You can find further informations here.
X
Lo Vullo, S
320  results:
Search for persons X
?
1

Predicting overall survival (OS) in patients (pts) with pen..:

Necchi, A. ; Mariani, L. ; Zhu, Y....
European Urology Supplements.  18 (2019)  1 - p. e648 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Activity of axitinib in progressive advanced solitary fibro..:

Stacchiotti, S. ; Simeone, N. ; Lo Vullo, S....
European Journal of Cancer.  106 (2019)  - p. 225-233 , 2019
Link: https://doi.org/10.1016/..
 
?
3

Impact of number of cycles of platinum-based first-line che..:

Necchi, A. ; Mariani, L. ; Lo Vullo, S....
European Urology Supplements.  17 (2018)  2 - p. e131-e132 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Pazopanib (PZP) in germ cell tumors (GCT) after chemotherap..:

Necchi, A. ; Lo Vullo, S. ; Giannatempo, P....
European Urology Supplements.  16 (2017)  3 - p. e1910-e1911 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Administration of high-dose chemotherapy with stem cell sup..:

Necchi, A ; Lo Vullo, S ; Rosti, G...
Bone Marrow Transplantation.  52 (2017)  8 - p. 1218-1220 , 2017
Link: https://doi.org/10.1038/..
 
?
6

Prognostic impact of fibroblast growth-factor receptor (FGF..:

Necchi, A. ; Lo Vullo, S. ; Gloghini, A..
European Urology Supplements.  16 (2017)  10 - p. e2806 , 2017
Link: https://doi.org/10.1016/..
 
?
7

Neoadjuvant sorafenib, gemcitabine, and cisplatin (SGC) for..:

Necchi, A. ; Lo Vullo, S. ; Raggi, D....
European Urology Supplements.  16 (2017)  3 - p. e293-e294 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Dacomitinib (Daco) induction therapy for locally-advanced (..:

Necchi, A. ; Lo Vullo, S. ; Raggi, D....
European Urology Supplements.  16 (2017)  3 - p. e1244-e1245 , 2017
Link: https://doi.org/10.1016/..
 
?
9

241 Prognostic factors of adjuvant chemotherapy with taxane..:

Necchi, A. ; Lo Vullo, S. ; Nicolai, N....
European Urology Supplements.  15 (2016)  3 - p. e241 , 2016
Link: https://doi.org/10.1016/..
 
?
10

1144 A phase 2 study of the Aurora Kinase-A (AAK) tyrosine ..:

Necchi, A. ; Raggi, D. ; Lo, Vullo S....
European Urology Supplements.  15 (2016)  3 - p. e1144 , 2016
Link: https://doi.org/10.1016/..
 
?
11

A phase II study of sorafenib in recurrent and/or metastati..:

Locati, L.D. ; Perrone, F. ; Cortelazzi, B....
European Journal of Cancer.  69 (2016)  - p. 158-165 , 2016
Link: https://doi.org/10.1016/..
 
?
12

598 Clinical outcomes of Intermediate Risk metastatic Germ ..:

Raggi, D. ; Lo, Vullo S. ; Giannatempo, P....
European Urology Supplements.  14 (2015)  2 - p. e598 , 2015
Link: https://doi.org/10.1016/..
 
?
13

120 The curative potential of lymphadenectomy after respons..:

Necchi, A. ; Lo Vullo, S. ; Giannatempo, P....
European Urology Supplements.  13 (2014)  1 - p. e120 , 2014
Link: https://doi.org/10.1016/..
 
?
14

6510 Sequential therapy with FOLFIRI followed by docetaxel ..:

Bartolomeo, M. Di ; Buzzoni, R. ; Lo Vullo, S....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 364 , 2009
Link: https://doi.org/10.1016/..
 
?
15

Melanoma of the anorectal region:

Belli, F. ; Gallino, G.F. ; Lo Vullo, S....
European Journal of Surgical Oncology (EJSO).  35 (2009)  7 - p. 757-762 , 2009
Link: https://doi.org/10.1016/..
 
1-15